S466-0364 Screening compound: N~1~-[1-(4-methoxyphenyl)ethyl]-2-[2-methyl-10-oxo-5,7,8,10-tetrahydropyrido[1,2-a]pyrrolo[3,2-d]pyrimidin-1(6H)-yl]acetamide

S466-0364 Screening compound: N~1~-[1-(4-methoxyphenyl)ethyl]-2-[2-methyl-10-oxo-5,7,8,10-tetrahydropyrido[1,2-a]pyrrolo[3,2-d]pyrimidin-1(6H)-yl]acetamide
S466-0364 Screening compound: N~1~-[1-(4-methoxyphenyl)ethyl]-2-[2-methyl-10-oxo-5,7,8,10-tetrahydropyrido[1,2-a]pyrrolo[3,2-d]pyrimidin-1(6H)-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S466-0364
N~1~-[1-(4-methoxyphenyl)ethyl]-2-[2-methyl-10-oxo-5,7,8,10-tetrahydropyrido[1,2-a]pyrrolo[3,2-d]pyrimidin-1(6H)-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S466-0364

Molecular Formula

C22H26N4O3 (C22 H26 N4 O3)

Compound Name

N~1~-[1-(4-methoxyphenyl)ethyl]-2-[2-methyl-10-oxo-5,7,8,10-tetrahydropyrido[1,2-a]pyrrolo[3,2-d]pyrimidin-1(6H)-yl]acetamide

IUPAC name

N-[1-(4-methoxyphenyl)ethyl]-2-{5-methyl-2-oxo-148-triazatricyclo[7.4.0.0^{37}]trideca-3(7)58-trien-4-yl}acetamide

SMILES

CC(c(cc1)ccc1OC)NC(Cn(c(C)c1)c2c1N=C(CCCC1)N1C2=O)=O

InChI

InChI=1S/C22H26N4O3/c1-14-12-18-21(22(28)25-11-5-4-6-19(25)24-18)26(14)13-20(27)23-15(2)16-7-9-17(29-3)10-8-16/h7-10,12,15H,4-6,11,13H2,1-3H3,(H,23,27)/t15-/m0/s1

InChI Key

OMMYRJOEWFADNJ-HNNXBMFYSA-N

MDL Number (MFCD)

MFCD29010781

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

394.47

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.781

Distribution Coefficient, logD

1.781

Water Solubility, LogSw

-2.43

Polar Surface Area

59.130

Acid Dissociation Constant (pKa)

13.81

Base Dissociation Constant (pKb)

1.75

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.90

S466-0364 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S466-0364 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S466-0364?
Check Price and Availability of S466-0364, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S466-0364 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S466-0364
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S466-0364
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S466-0364 available by request